Compare KEP & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KEP | RVTY |
|---|---|---|
| Founded | 1961 | 1937 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 17.0B |
| IPO Year | 1996 | 1994 |
| Metric | KEP | RVTY |
|---|---|---|
| Price | $10.64 | $166.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $149.87 |
| AVG Volume (30 Days) | 850.5K | ★ 1.7M |
| Earning Date | 11-17-2026 | 11-03-2026 |
| Dividend Yield | ★ 3.91% | 0.17% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $0.25 | $0.58 |
| Revenue Next Year | $1.46 | $5.51 |
| P/E Ratio | ★ $4.54 | $201.34 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.26 | $81.22 |
| 52 Week High | $23.41 | $171.74 |
| Indicator | KEP | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 64.42 |
| Support Level | $10.43 | $143.39 |
| Resistance Level | $12.74 | N/A |
| Average True Range (ATR) | 0.19 | 6.44 |
| MACD | 0.02 | -0.25 |
| Stochastic Oscillator | 59.84 | 87.10 |
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.